1-methyl-3-[(Z)-[(1Z)-1-(methylcarbamothioylhydrazinylidene)-1-phenylpropan-2-ylidene]amino]thiourea

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-methyl-3-[(Z)-[(1Z)-1-(methylcarbamothioylhydrazinylidene)-1-phenylpropan-2-ylidene]amino]thiourea
• 化学式: C₁₃H₁₈N₆S₂
• 分子量: 322.5
• InChiKey: IIYWMJZKABJHJV-KKYJLSSQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  137
• 氢给体数：
  4
• 氢受体数：
  4

文献信息

• [EN] THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING SAME<br/>[FR] COMPLEXES DE MÉTAL THÉRAPEUTIQUES ET LIGANDS, LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
  申请人：UNIV OREGON STATE

  公开号：WO2019046761A1

  公开（公告）日：2019-03-07

  Disclosed herein are compound embodiments that are useful for treating a variety of diseases, particularly neurological diseases, motor neuron diseases, copper deficiency-related diseases, and/or mitochondrial deficiencies. The compound embodiments described herein also can be used in PET methods. Also disclosed herein are embodiments of methods of making and using the compound embodiments, as well as pharmaceutical formulations comprising the disclosed compound embodiments.

  本文披露了一种化合物实施例，可用于治疗各种疾病，特别是神经系统疾病、运动神经元疾病、铜缺乏相关疾病和/或线粒体缺陷。本文还披露了这些化合物实施例可用于PET方法。本文还披露了制备和使用这些化合物实施例的方法实施例，以及包含所披露的化合物实施例的药物配方。
• THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING THE SAME
  申请人：Oregon State University

  公开号：US20200188430A1

  公开（公告）日：2020-06-18

  Disclosed herein are compound embodiments that are useful for treating a variety of diseases, particularly neurological diseases, motor neuron diseases, copper deficiency-related diseases, and/or mitochondrial deficiencies. The compound embodiments described herein also can be used in PET methods. Also disclosed herein are embodiments of methods of making and using the compound embodiments, as well as pharmaceutical formulations comprising the disclosed compound embodiments.